California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.


Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Neuralink Expands Brain Implant Trials with 12 Global Patients
Asian Markets Slide as New U.S. Strikes on Iran Spark Investor Caution
Asian Stocks Rally as AI Boom and Iran Ceasefire Progress Lift Market Sentiment
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions
Iran-U.S. Nuclear Talks Remain Unresolved as Strait of Hormuz Risks Keep Markets on Edge
Tokyo Inflation Cools in May, Supporting BOJ’s Cautious Rate Hike Path
UK Grocery Inflation Slows to 3.1% as Supermarket Price Pressures Ease in May 2026
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 



